Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 200

Kindbody gets $32m in funding benefits

NFP and Alphabet's GV unit contributed to a series B round that will help the fertility and gynaecology services startup expand its brick-and-mortar outlets.

Jul 13, 2020

Tranquis races out of the traps with $30m

The neurodegenerative disease startup has emerged from stealth with $30m taken in a series A round co-led by GlaxoSmithKline's SR One unit.

Jul 13, 2020

Corporate venturing deal net: 6-10 July 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jul 10, 2020

Harbour BioMed hoards $103m

The SK Holdings, China Life and Legend Holdings-backed cancer and inflammatory disease drug developer has now raised more than $260m in under two years.

Jul 10, 2020

Doctor on Demand prescribes $75m series D

General Atlantic led a $75m series D round for Doctor on Demand, a virtual care provider with shareholders including GV, Qualcomm Ventures and Dignify Health.

Jul 10, 2020

LumiThera sees light in $14m series C

Nikon was among the investors that helped the eye disease treatment developer close a round that pushed its overall funding to $24m.

Jul 9, 2020

Truepill fulfils $25m series B

Optum Ventures helped the prescription fulfilment platform push its total funding to more than $39m, with the cash to fund product development.

Jul 9, 2020

WBA moves into VillageMD with $250m

VillageMD is set to receive a total of $1bn in equity and convertible debt financing from Walgreens Boots Alliance over the next three years, giving the corporate a 30% stake.

Jul 9, 2020

VelosBio sells investors on $137m series B

The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.

Jul 9, 2020

VarmX arms itself with series B cash

Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.

Jul 9, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here